Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Emazole 40mg Gastro-Resistant Tablet – PA0711/158/002
- Fludrocortisone 0.1mg Tablet – PA1691/018/001
- Foznol 750mg Chewable Tablet – PA1575/002/003
- Foznol 1000mg Chewable Tablet – PA1575/002/004
- Hytrin 2mg Tablet – PA1142/005/002
- Hytrin 10mg Tablet – PA1142/005/004
- RoActemra 162mg Solution for Injection in Prefilled Pen – EU/1/08/492/009-010
- Ultiva 5mg Powder for Concentrate for Solution for Infusion – PA1691/032/003
- Valdoxan 25mg Film Coated Tablet – EU/1/08/499/003
- Zaditen 1mg Tablet – PA2206/004/002
- Zomig 2.5mg Tablet – PA2242/004/001
The following shortage has been resolved and supply has resumed to the Irish market:
- Bendamustine 25mg Powder for Solution for Infusion – PA1380/163/001
- Canesten Combi 500mg Pessary & 2% Cream – PA1410/039/001
- Co-Amoxiclav 500mg/100mg Powder for Solution for Injection and Infusion – PA1457/001/001
- Lotanos 50mg Tablet – PA0711/123/003
- Olmesartan Rowex 10mg Tablet – PA0711/1255/001
- Zorclone 7.5mg Tablet – PA1986/080/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.